Avoid Valeant (VRX) Stock?

Valeant Pharmaceuticals International (VRX 37.00) has garnered a lot of news lately. Valeant's stock continues to rise after the company won approval from loan holders to amend terms of the company’s debt, granting the pharmaceutical company an additional month to file its annual report.
Read More

A Simple Value Strategy Beat the Hedge Fund!

The S&P 500 rose 7.6% this month through October 27, the Dow rose 8.0% and the NASDAQ rose 9.0%. You'd think the financial press would be rejoicing, and congratulating individual investors for holding on through the August stock market downturn, or—gasp!—being wise enough to low...
Read More

Trophy Growth Stocks

Growth investing is like deep-sea fishing for tuna. You spend a lot of time and effort preparing, getting the right equipment, selecting your path, using the right bait and starting your trawling run.
Read More

A Stock with a Good Risk-Reward Set-Up

I’m playing things cautiously for the moment. On the buy side, I’m looking for stocks that are (a) acting calmly despite the choppy action and (b) are near support, so I can use tight loss limits to limit risk if things go awry.
Read More

Party Stocks!

One of my favorite mutual funds used to be an offering from a big Boston investment house called “The Cocktail Party Fund.”
Read More